Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians

被引:81
作者
Remme, Willem J. [1 ]
McMurray, John J. V. [3 ]
Hobbs, F. D. Richard [2 ]
Cohen-Solal, Alain [4 ]
Lopez-Sendon, Jose [5 ]
Boccanelli, Alessandro [6 ]
Zannad, Faiez [7 ]
Rauch, Bernhard [8 ]
Keukelaar, Karen [1 ]
Macarie, Cezar [9 ]
Ruzyllo, Witold [10 ]
Cline, Charles [11 ]
机构
[1] Sticares Cardiovasc Res Fdn, NL-3160 AB Rhoon, Netherlands
[2] Univ Birmingham, Birmingham, W Midlands, England
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Hop Lariboisiere, F-75475 Paris, France
[5] Hosp Univ Gregorio Maranon, Madrid, Spain
[6] Osped S Giovanni Addolorata, Rome, Italy
[7] CHU Nancy, Hop Brabois, Nancy, France
[8] Inst Herzinfarktforsch, Ludwigshafen, Germany
[9] Inst Boli Cardiovasc C C Iliescu, Bucharest, Romania
[10] Natl Inst Cardiol, Warsaw, Poland
[11] Karolinska Univ Hosp, Stockholm, Sweden
关键词
heart failure; awareness; perception; Europe; guidelines; diagnosis; treatment; advice; cardiologists; internists; geriatricians; primary care physicians; ACE inhibition; beta-blockade; aldosterone antagonists; diuretics; echocardiography; heart failure nurses;
D O I
10.1093/eurheartj/ehn196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To assess awareness of heart failure (HF) management recommendations in Europe among cardiologists (C), internists and geriatricians (I/G), and primary care physicians (PCPs). Methods and results The Study group on HF Awareness and Perception in Europe (SHAPE) surveyed randomly selected C (2041), I/G (1881), and PCP (2965) in France, Germany, Italy, the Netherlands, Poland, Romania, Spain, Sweden, and the UK. Each physician completed a 32-item questionnaire about the diagnosis and treatment of HF (left ventricular ejection fraction < 40%). This report provides an analysis of HF awareness among C, I/G, and PCP. Seventy-one per cent I/G and 92% C use echocardiography, and 43% I/G and 82% C use echo-Doppler as a routine diagnostic test (both P < 0.0001). In contrast, 75% PCP use signs and symptoms to diagnose HF. Fewer I/G would use an angiotensin-converting enzyme (ACE)-inhibitor in > 90% of their patients (64 vs. 82% C, P < 0.0001), whereas only 47% PCP would routinely prescribe an ACE-inhibitor. Worsening HF was considered a risk of ACE-inhibitor therapy by 35% PCP. I/G and PCP consistently do not prescribe target ACE-inhibitor doses (P < 0.0001 vs. C). Only 39% I/G would use a beta-blocker in > 50% of their patients (vs. 73% C, P < 0.0001). Also, only 5% PCP would always, and 35% often, prescribe a beta-blocker and reach target doses in only 7-29%. Moreover, 34% PCP and 26% I/G vs. 11% C (P < 0.0001) do not start a beta-blocker in patients with mild HF, who are already on an ACE-inhibitor and are on diuretic. In mild, stable HF, 39% PCP and 18% I/G would only prescribe diuretics, vs. 7% C (P < 0.0001). In patients with worsening HF in sinus rhythm and on an optimal ACE-inhibitor, beta-blockade and diuretics, significantly more C would add spironolactone, but I/G would more often add digoxin. Conclusions Although each physician group lacks complete adherence to guideline-recommended management strategies, these are used significantly less well by I, G, and PCPs, indicating the need for education of these essential healthcare providers.
引用
收藏
页码:1739 / 1752
页数:14
相关论文
共 27 条
[1]   Cardiac resynchronization in chronic heart failure [J].
Abraham, WT ;
Fisher, WG ;
Smith, AL ;
Delurgio, DB ;
Leon, AR ;
Loh, E ;
Kocovic, DZ ;
Packer, M ;
Clavell, AL ;
Hayes, DL ;
Ellestad, M ;
Messenger, J ;
Trupp, RJ ;
Underwood, J ;
Pickering, F ;
Truex, C ;
McAtee, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) :1845-1853
[2]   Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure - The OSCUR study [J].
Bellotti, R ;
Badano, LP ;
Acquarone, N ;
Griffo, R ;
Lo Pinto, G ;
Maggioni, AP ;
Mattiauda, C ;
Menardo, G ;
Mombelloni, P .
EUROPEAN HEART JOURNAL, 2001, 22 (07) :596-604
[3]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[4]  
CLELAND JG, 1995, EUR HEART J, V16, P741
[5]   Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey [J].
Cleland, JGF ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Eastaugh, J ;
Follath, F ;
Freemantle, N ;
Gavazzi, A ;
van Gilst, WH ;
Hobbs, FDR ;
Korewicki, J ;
Madeira, HC ;
Preda, I ;
Swedberg, K ;
Widimsky, J .
LANCET, 2002, 360 (9346) :1631-1639
[6]   The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].
Cleland, JGF ;
Swedberg, K ;
Follath, F ;
Komajda, M ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Gavazzi, A ;
Hobbs, R ;
Korewicki, J ;
Madeira, HC ;
Moiseyev, VS ;
Preda, I ;
van Gilst, WH ;
Widimsky, J ;
Freemantle, N ;
Eastaugh, J ;
Mason, J .
EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463
[7]   A national survey of heart failure in French hospitals [J].
Cohen-Solal, A ;
Desnos, M ;
Delahaye, F ;
Emeriau, JP ;
Hanania, G .
EUROPEAN HEART JOURNAL, 2000, 21 (09) :763-769
[8]   Improving the use of evidence-based heart failure therapies in the outpatient setting: The IMPROVE HF performance improvement registry [J].
Fonarow, Gregg C. ;
Yancy, Clyde W. ;
Albert, Nancy M. ;
Curtis, Anne B. ;
Stough, Wendy Gattis ;
Gheorghlade, Mihai ;
Heywood, J. Thomas ;
Mehra, Mandeep ;
O'Connor, Christopher M. ;
Reynolds, Dwight ;
Walsh, Mary Norine .
AMERICAN HEART JOURNAL, 2007, 154 (01) :12-38
[9]   Tolerability of β-blocker initiation and titration in the metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) [J].
Gottlieb, SS ;
Fisher, ML ;
Kjekshus, J ;
Deedwania, P ;
Gullestad, L ;
Vitovec, J ;
Wikstrand, J .
CIRCULATION, 2002, 105 (10) :1182-1188
[10]  
Hjalmarson Å, 1999, LANCET, V353, P2001